Previously, PD-L1 expression has been reported to be associated with worse prognosis of triple negative breast cancer patients, which counteract effect of tumor-infiltrating lymphocytes (TILs) [10]. This evidence concerns the gene CD274 and triple-negative breast carcinoma.